211 related articles for article (PubMed ID: 15702884)
21. A nonthiazolidinedione peroxisome proliferator-activated receptor α/γ dual agonist CG301360 alleviates insulin resistance and lipid dysregulation in db/db mice.
Jeong HW; Lee JW; Kim WS; Choe SS; Shin HJ; Lee GY; Shin D; Lee JH; Choi EB; Lee HK; Yon GH; Cho B; Kim HR; Choi SH; Chung YS; Park SB; Chung H; Ro S; Kim JB
Mol Pharmacol; 2010 Nov; 78(5):877-85. PubMed ID: 20724462
[TBL] [Abstract][Full Text] [Related]
22. PPARs at the crossroads of lipid signaling and inflammation.
Wahli W; Michalik L
Trends Endocrinol Metab; 2012 Jul; 23(7):351-63. PubMed ID: 22704720
[TBL] [Abstract][Full Text] [Related]
23. Regulation of lipid metabolism and peroxisome proliferator-activated receptors in rainbow trout adipose tissue by lipolytic and antilipolytic endocrine factors.
Cruz-Garcia L; Sánchez-Gurmaches J; Monroy M; Gutiérrez J; Navarro I
Domest Anim Endocrinol; 2015 Apr; 51():86-95. PubMed ID: 25594950
[TBL] [Abstract][Full Text] [Related]
24. Effect of medium- and long-chain fatty acid diets on PPAR and SREBP-1 expression and glucose homeostasis in ACBP-overexpressing transgenic rats.
Oikari S; Ahtialansaari T; Huotari A; Kiehne K; Fölsch UR; Wolffram S; Jänne J; Alhonen L; Herzig KH
Acta Physiol (Oxf); 2008 Sep; 194(1):57-65. PubMed ID: 18394026
[TBL] [Abstract][Full Text] [Related]
25. [PPARs target genes].
Takada I; Kato S
Nihon Rinsho; 2005 Apr; 63(4):573-7. PubMed ID: 15828222
[TBL] [Abstract][Full Text] [Related]
26. Pivotal Roles of Peroxisome Proliferator-Activated Receptors (PPARs) and Their Signal Cascade for Cellular and Whole-Body Energy Homeostasis.
Lamichane S; Dahal Lamichane B; Kwon SM
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29565812
[TBL] [Abstract][Full Text] [Related]
27. Peroxisome proliferator-activated receptor: effects on nutritional homeostasis, obesity and diabetes mellitus.
Viana Abranches M; Esteves de Oliveira FC; Bressan J
Nutr Hosp; 2011; 26(2):271-9. PubMed ID: 21666962
[TBL] [Abstract][Full Text] [Related]
28. [PPAR receptors: recent data].
Vidal H
Ann Endocrinol (Paris); 2005 Apr; 66(2 Pt 2):1S5-9. PubMed ID: 15959399
[TBL] [Abstract][Full Text] [Related]
29. Roles of PPARs on regulating myocardial energy and lipid homeostasis.
Yang Q; Li Y
J Mol Med (Berl); 2007 Jul; 85(7):697-706. PubMed ID: 17356846
[TBL] [Abstract][Full Text] [Related]
30. Role of the PPAR family of nuclear receptors in the regulation of metabolic and cardiovascular homeostasis: new approaches to therapy.
Chinetti-Gbaguidi G; Fruchart JC; Staels B
Curr Opin Pharmacol; 2005 Apr; 5(2):177-83. PubMed ID: 15780828
[TBL] [Abstract][Full Text] [Related]
31. From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions.
Feige JN; Gelman L; Michalik L; Desvergne B; Wahli W
Prog Lipid Res; 2006 Mar; 45(2):120-59. PubMed ID: 16476485
[TBL] [Abstract][Full Text] [Related]
32. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice.
Verreth W; De Keyzer D; Pelat M; Verhamme P; Ganame J; Bielicki JK; Mertens A; Quarck R; Benhabilès N; Marguerie G; Mackness B; Mackness M; Ninio E; Herregods MC; Balligand JL; Holvoet P
Circulation; 2004 Nov; 110(20):3259-69. PubMed ID: 15533870
[TBL] [Abstract][Full Text] [Related]
33. [PPARs-mediated intracellular signal transduction].
Fujii H
Nihon Rinsho; 2005 Apr; 63(4):565-71. PubMed ID: 15828221
[TBL] [Abstract][Full Text] [Related]
34. Peroxisome proliferator-activated receptors: how their effects on macrophages can lead to the development of a new drug therapy against atherosclerosis.
Li AC; Palinski W
Annu Rev Pharmacol Toxicol; 2006; 46():1-39. PubMed ID: 16402897
[TBL] [Abstract][Full Text] [Related]
35. [PPARgamma and atheroma].
Staels B
Ann Endocrinol (Paris); 2002 Apr; 63(2 Pt 2):1S23-6. PubMed ID: 12037504
[TBL] [Abstract][Full Text] [Related]
36. [Role of the peroxisome proliferator-activated receptors (PPARS) in the regulation of lipids and inflammation control].
Bocher V; Chinetti G; Fruchart JC; Staels B
J Soc Biol; 2002; 196(1):47-52. PubMed ID: 12134632
[TBL] [Abstract][Full Text] [Related]
37. [Polymorphisms of PPARs and metabolic disorders].
Araki E; Igata M; Motoshima H; Tsuruzoe K
Nihon Rinsho; 2005 Apr; 63(4):617-22. PubMed ID: 15828229
[TBL] [Abstract][Full Text] [Related]
38. Phospholipase A2-modified low-density lipoprotein activates macrophage peroxisome proliferator-activated receptors.
Namgaladze D; Morbitzer D; von Knethen A; Brüne B
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):313-20. PubMed ID: 19948841
[TBL] [Abstract][Full Text] [Related]
39. Peroxisome proliferator-activated receptors as sensors of fatty acids and derivatives.
Grimaldi PA
Cell Mol Life Sci; 2007 Oct; 64(19-20):2459-64. PubMed ID: 17876521
[TBL] [Abstract][Full Text] [Related]
40. [Application of the human hepatoblastoma cell lines inducibly expressing peroxisome proliferator-activated receptors (PPARs)].
Tachibana K
Yakugaku Zasshi; 2007 Aug; 127(8):1223-9. PubMed ID: 17666873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
